Stay informed with the latest updates for the inheritable blood disorders community. IndustryGreen Cross Initiates Phase III Trial of rFVIII ProductFeb 1, 2013 IndustryBaxter Announces Inhibitor Study Results, Acquisition of Inspiration…Feb 1, 2013 IndustryBiogen Idec Submits FDA Application for Long-Acting FIX TherapyFeb 1, 2013 IndustryBaxter Presents Data on Developmental Recombinant FIX ProductJan 1, 2013 IndustryNovo Nordisk Seeks Regulatory Approval for Recombinant FVIII DrugNov 1, 2012 IndustryAbbott Announces Success in HCV Triple Drug Combo TrialNov 1, 2012 IndustryFDA Rescinds Exclusivity for Octapharma's WilateSep 1, 2012 IndustryInspiration Announces Global Agreement with IpsenSep 1, 2012 IndustrySetbacks for Hepatitis C Drugs in Clinical TrialsSep 1, 2012 IndustryBaxter Announces New ADVATE Dosage StrengthAug 1, 2012 IndustryFDA Puts Clinical Hold on Inspiration's Trials of rFIXAug 1, 2012 IndustryBayer Announces 2012 BHAP Award RecipientsAug 1, 2012 IndustryBayer Enrolls Patients in Longer-acting rFVIII Trial, Announces…Aug 1, 2012 IndustryNovo Nordisk Announces HERO Study ResultsAug 1, 2012 IndustryBaxter and Chatham Partner to Develop Hemophilia TreatmentsJul 1, 2012 Pagination First page Previous page … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 Next page Last page
